Show simple item record

dc.contributor.authorHacisahinogullari, Hulya
dc.contributor.authorDinccag, Nevin
dc.contributor.authorTekin, Sakin
dc.contributor.authorTanrikulu, Seher
dc.contributor.authorKoc, Mehmet S.
dc.contributor.authorCakmak, Ramazan
dc.contributor.authorCaklili, Ozge T.
dc.date.accessioned2022-02-18T11:29:19Z
dc.date.available2022-02-18T11:29:19Z
dc.identifier.citationCakmak R., Caklili O. T. , Tekin S., Hacisahinogullari H., Tanrikulu S., Koc M. S. , Dinccag N., "Comparison of amylase and lipase levels of patients with Type 2 diabetes under different treatment modalities", BIOMARKERS IN MEDICINE, 2021
dc.identifier.issn1752-0363
dc.identifier.othervv_1032021
dc.identifier.otherav_fd2e74cd-552a-46cd-82d8-c9fd5dfb2fd3
dc.identifier.urihttp://hdl.handle.net/20.500.12627/181294
dc.identifier.urihttps://doi.org/10.2217/bmm-2021-0318
dc.description.abstractAim: Study aims to assess amylase, lipase of patients with Type 2 diabetes under different types of treatments. Materials & methods: Patients' treatment modalities including insulin, metformin, pioglitazone, sodium-glucose co-transporter-2 inhibitors, insulin secretagogues, dipeptidyl peptidase-4 inhibitors and glucagon like peptide-1 receptor agonists were compared. Results: There was no difference in amylase and lipase levels between dipeptidyl peptidase-4 inhibitor users and non-users (p = 0.2, p = 0.3, respectively) and glucagon like peptide-1 analog users and non-users (p = 0.1, p = 0.7, respectively). Patients who use insulin secretagogues had significantly higher amylase, lipase and (77.2 +/- 39.8 vs 69.5 +/- 33.0, p = 0,038 and 47.2 +/- 33.2 vs 39.6 +/- 26.8, p = 0.01, respectively) patients on basal insulin had lower amylase levels (69.9 +/- 37.7 vs 77.2 +/- 33.7, p = 0.014). Conclusion: Incretin-based therapies showed no difference in amylase and lipase levels whereas there was increase with secretagogues and decrease with basal insulin.
dc.language.isoeng
dc.subjectReviews and References (medical)
dc.subjectResearch and Theory
dc.subjectHealth Sciences
dc.subjectDahili Tıp Bilimleri
dc.subjectTıbbi Ekoloji ve Hidroklimatoloji
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIP, ARAŞTIRMA VE DENEYSEL
dc.titleComparison of amylase and lipase levels of patients with Type 2 diabetes under different treatment modalities
dc.typeMakale
dc.relation.journalBIOMARKERS IN MEDICINE
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Bilimler
dc.contributor.firstauthorID2773381


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record